FDA-approved Immune & defense

Cyclosporine

Cyclosporine is a cyclic peptide immunosuppressant. It is filed in this library under immune & defense, a navigation topic rather than a statement of where it acts. As a regulatory matter it has at least one product approved by the FDA.

Regulatory status

Cyclosporine has an FDA-approved product on the U.S. market, marketed as Vevye under application NDA217469.

The current label is held by Harrow Eye, LLC.

From the FDA label

What Cyclosporine is approved to treat

indicated for the treatment of the signs and symptoms of dry eye disease.Quoted from the FDA-approved prescribing information

The evidence

What has actually been published

One source on Cyclosporine, resolved to its journal of record. The title is listed so you can judge the evidence rather than take a summary on trust.

Nearby

Other peptides acting on immune & defense

Not sure what applies to you?

A 60-second questionnaire, reviewed by a U.S.-licensed physician.

Find my protocol

Educational reference only. This page explains what has been published about Cyclosporine. It is not medical advice, it is not a diagnosis, and it carries no dosing information of any kind. OPTML does not offer or supply this compound unless a product page on this site says otherwise.

Treatment decisions are made by a licensed physician after an individual evaluation. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.

All 150 peptides